Jio Financial Services Allots 25 Crore Shares to Promoter Group Entities
"Following the allotment, the combined shareholding of the promoter and promoter group has increased from 49.13% to 50.98%."
Jio Financial Services Completes Preferential Share Allotment
The company's Stakeholders' Relationship Committee approved the allotment of 25 crore equity shares after receiving the conversion amount for the remaining preferential warrants. Both recipients are part of the promoter group.
The allotment increases the individual shareholding of both entities in Jio Financial Services and raises the overall promoter group stake in the company.
Allotment and Shareholding Details
- Total shares allotted: 25,00,00,000 equity shares
- Face value: Rs. 10 per share
- Issue premium: Rs. 306.50 per share
- Allotment price: Rs. 316.50 per share
- Sikka Ports & Terminals Limited: Received 12.50 crore shares, increasing its stake from 2.93% to 4.65%
- Jamnagar Utilities & Power Private Limited: Received 12.50 crore shares, increasing its stake from 3.84% to 5.52%
- Allotment category: Conversion of preferential warrants
- Promoter and promoter group holding: Increased from 49.13% to 50.98%
What to Watch Next
Investors will track further changes in promoter shareholding and any additional disclosures related to the conversion of preferential warrants. The increased promoter group stake will also be relevant when assessing the company's ownership structure.
Disclaimer
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)
Other News
Natco Pharma Promoters and Promoter Group Acquire 22.11 Lakh Shares Through Rights Issue
Natco Pharma Limited’s promoters and promoter group entities have acquired 22,11,776 equity shares through the company’s Rights Issue. The shares were allotted on October 26, 2026, at Rs 750 per share, taking the total value of acquisition to about Rs. 165.88 crore. The company’s paid up equity share capital increased to 19,61,67,952 equity shares following the Rights Issue.
Ginni Filaments: SBICAP Trustee Releases Encumbrance on 26.48 Lakh Shares
SBICAP Trustee Company Limited has disclosed the release of encumbrance on 26,48,300 equity shares of Ginni Filaments Limited under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The released shares represent 3.09% of the total voting share capital of Ginni Filaments. Following the transaction dated October 29, 2026, SBICAP Trustee's encumbered shareholding declined from 1,04,08,300 equity shares (12.15%) to 77,60,000 equity shares (9.06%). The transaction was executed by SBICAP Trustee Company Limited in its capacity as a Security Trustee. The entity does not belong to the promoter or promoter group of Ginni Filaments.
Sun Pharma Gets US FDA Approval for ILUMYA to Treat Psoriatic Arthritis
Sun Pharmaceutical Industries has received US FDA approval for ILUMYA (tildrakizumab-asmn) to treat adults with active psoriatic arthritis (PsA). The approval expands the drug's use beyond plaque psoriasis and gives the company access to another segment of the US immunology market.